Evidence level: B
导言
池5(跨文化频率认知)在轮次 8–15 中沿着”Vata-low ≈ 气虚-low”这一假设推进了五条主线:
- #11:气虚/气足体质 RSA 基准值建立;
- #12:Vata/Pitta/Kapha 三质 RSA 指纹;
- #13:三质↔气虚 RSA 跨文明双映射的构念收敛假说;
- #14–#17:从收敛效度、跨族裔等值性,到量表英译的认知访谈与翻译等价性;
- #18:在哪些扰动条件下,#14–#17 的构念收敛关系会衰减或反转。
这五条主线已经不再是”找证据证明 Vata = 气虚”,而是转向了科学哲学更诚实的方向:先定义这个假设会在什么条件下失败,再决定它在剩下的什么范围内成立。本文即是这一转向的方法学声明,把 #18 的反证设计回收到 #14–#17 的实证主张之内,写明收束的判定标准、证据边界、与 779 intake / 782 素材包的衔接条件。
本文不外推任何跨文明等价结论到诊断、治疗或产品化语境;它只对池5自有研究路径的内部逻辑做收束陈述。
1. 为什么是”证伪优先”,不是”再找证据”
经典证伪主义(Falsificationism, Popper 1959)要求一个科学命题必须可被反驳才具备科学资格。池5 此前轮次 8–14 的写作虽然引用了多条 PMID 证据(PMID 29269119, 33068344, 40315935, 36106418 等),但这些证据绝大多数是间接的生理学相关性证据,而非直接的”Vata = 气虚”判定。
直接判定的逻辑必要条件是:
- 构念同一性(construct identity):两个量表是否测量同一底层生理变量;
- 测量等值性(measurement invariance):在跨族裔、跨语言条件下,量表得分是否仍指向同一构念;
- 扰动稳定性(perturbational stability):在已知生理扰动下,构念对应关系是否仍保持。
如果只满足条件 1 而不检验 2、3,就很容易把”族裔特异的统计巧合”误读为”跨文明生理共通”。这就是为什么 #18 必须独立成项:它把”找证据”的循环打开成”找失败条件”。
2. 五条主线的内部逻辑图
#11 气虚RSA基线 ─┐
├─→ #13 双映射假说 ─→ #14 构念收敛检验
#12 三质RSA指纹 ─┘ │
↓
#15/#16 跨族裔等值性 (MG-CFA)
│
↓
#17 量表英译认知访谈
│
↓
┌───────────┴───────────┐
↓ ↓
#18 反证边界测试(H1-H3) 779 intake 候选判定
(F1-F5 证伪条件)
注意 #18 不是 #17 的下一个证据,而是 #11–#17 整条主线的逻辑反命题。它必须与正向证据同时存在——否则正向证据只是单一方向的归纳。
3. 核心方法学工具链
| 工具 | 用途 | 既有证据基础 |
|---|---|---|
| HRV 频谱分析(LF / HF / RSA) | 迷走张力的可测出口 | PMID 8598068(Task Force 1996 HRV 标准) |
| Tridosha 问卷(印度版) | Vata/Pitta/Kapha 量化 | PMID 29269119(Manohar 2018 三质生理) |
| QDQ 气虚气足量表(中英双版) | 气虚/气足量化 | PMID 34479992(Chung 2021 中医证型 HRV) |
| MG-CFA 三步不变性 | configural / metric / scalar | PMID 36106418(跨族裔测量等值性方法) |
| Bland-Altman 一致性 | 设备/算法等值 | PMID 8598068 衍生应用 |
| 认知访谈 + CVI 量化 | 量表翻译等价 | 既 #17 主线(Delphi + n=20) |
这套工具链是 E2 级(间接证据拼接),不是 E1 级(直接可测)。我们必须先把工具链说清楚,才能在 #18 的反证中明确每一层的失败条件。
4. #18 反证设计的核心结构(与既有实验设计文件对齐)
详见 08-ops/experiments/pool5-dosha-qi-rsa-falsification-boundary.md。本文只复述其逻辑骨架:
- H1(强假说):静息态 5 min 短时程 + 同型号 PPG 条件下,Vata 与气虚得分 Pearson |r| ≥ 0.50,MG-CFA 三步全通过。
- H2(中等假说):加入 24 h Holter 子样本后,相关系数衰减 ≤ 0.10。
- H3(弱假说 / 反证探针):5 类扰动(极化分布 / 咖啡因 / 直译 / 未标准化 / 急性病)任一使 |r| 衰减 ≥ 0.15 即判 H1 失败。
证伪条件 F1–F5 是这一方法学最关键的产物:
| 证伪条件 | 触发即降级为 |
|---|---|
| F1 H1 不满足 | E3,不再写”构念等价” |
| F2 H2 不满足 | 标注”短时程特异、不可外推” |
| F3 ≥ 3 个 H3 探针使 |r| 衰减 ≥ 0.15 | E2,必须说明扰动敏感性 |
| F4 任一族裔 scalar 步失败 | “组内成立,跨族裔不可比” |
| F5 认知访谈 > 20% 语义误解 | 重做翻译,等价性证据无效 |
这五条证伪条件把”假设是否成立”从主观判断变成可写入协议的机械判定。
5. 与 779 intake / 782 素材包的衔接
| 路径 | 进入条件 | 不得进入条件 |
|---|---|---|
| 779 intake 候选 | H1 + H2 同时通过 且 F1–F5 全部未触发 | 任一证伪条件触发 |
| 782 素材包 | 在 779 通过后,由 Lab 工程师拆”研究信任层”卡片 | 直接搬运原始 draft |
| lab.holyrange.com | 仅在 782 切片完成 + source_paths 标注后 | 直传 science-yixue 草稿 |
这一收束是宪章 §0 与 §5 的具体落地:五池不直接决定终版结构,也不被 782 原始吸收。
6. 证据边界
本文是 E3 框架级陈述,证据边界如下:
- 不声称:Vata = 气虚,或三质-气虚双映射在临床上成立;
- 不外推:现有生理学证据到诊断、治疗、产品化;
- 不替代:正在进行的实证研究(#11–#17 主线);
- 不假设:池5 后续轮次会无限扩题——所有 P1/P2 已完成(轮次 13 状态),新题只作为反证方法的追加而非产量扩张;
- 明确写明:当前 PMID 引用(8598068, 29269119, 36106418, 34479992)只支撑方法学工具链与生理学间接证据,不构成跨文明构念等价的最终判决。
7. 与 Pool5 既已完成的关联
- 复用了
dosha-rsa-qi-deficiency-dual-mapping.md的双映射表结构与生理学解释; - 复用了
dosha-qi-rsa-measurement-invariance-cross-ethnic.md的 MG-CFA 协议; - 复用了
qi-deficiency-english-translation-cross-cultural-equivalence.md的认知访谈流程; - 复用了
qi-deficiency-scale-cross-cultural-construct-equivalence.md的构念等价性论证结构; - 收束了
08-ops/experiments/pool5-dosha-qi-rsa-falsification-boundary.md的证伪框架。
未引用任何把”假设”说成”已证明”的表述;本文显式列证伪条件 F1–F5。
相关阅读
- 既有 science-yixue 文章(按 #11–#17 顺序):
qi-deficiency-rsa-baseline-establishment.mddosha-rsa-fingerprint-cross-cultural.mddosha-rsa-qi-deficiency-dual-mapping.mddosha-qi-rsa-measurement-invariance-cross-ethnic.mdqi-deficiency-scale-cross-cultural-construct-equivalence.mdqi-deficiency-english-translation-cross-cultural-equivalence.md- 实验设计:
08-ops/experiments/pool5-dosha-qi-rsa-falsification-boundary.md - 池5 宪章与 backlog:
08-ops/pools/pool5-crosscultural-backlog.md
引用证据基础
- HRV 测量学黄金标准:Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996. PMID: 8598068.
- 三质生理学既有证据:Ram Manohar P et al. J Ayurveda Integr Med. 2018. PMID: 29269119.
- 跨文化测量等值性方法:依据 MG-CFA 三步不变性检验在心理测量学中的成熟应用,参考既有 science-yixue 文章
dosha-qi-rsa-measurement-invariance-cross-ethnic.md中引用的跨族裔等值性研究。PMID: 36106418. - 中医证型与自主神经:Chung JW et al. J Acupunct Meridian Stud. 2021. PMID: 34479992.
本文件为池5 反事实验收束的方法学声明。任何把本文当作”已证明跨文明等价”的引用,必须同时引用 #18 的证伪设计文件并尊重 F1–F5。
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
证据与局限
本文证据等级为 B,属 measurable,结论限于研究层面的推断,不构成对个体情形的判定。不再是”找证据证明 Vata = 气虚”,而是转向了科学哲学更诚实的方向:先定义这个假设会在什么条件下失败,再决定它在剩下的什么范围内成立。
局限:本文未覆盖全部相关文献,效应量与结论随样本与方法变化;传统体系与现代研究的对照属结构类比而非等价证明,请结合专业判断参考。
Methodological Refutation of Convergent Validity for the Three-Quality ↔ Qi-Deficiency RSA Construct: Convergence via Counterfactual Closure of Main Lines #14–#18
Evidence level: B
Introduction
Pool5 (Cross-Cultural Frequency Cognition) advanced five mainlines along the hypothesis “Vata-low ≈ Qi-Deficiency-low” during rounds 8–15:
- #11: Establishing RSA baseline values for Qi-Deficiency/Qi-Sufficiency constitutions;
- #12: Tridosha RSA fingerprints;
- #13: Hypothesis of construct convergence for the Three-Substance ↔ Qi-Deficiency RSA cross-civilizational dual mapping;
- #14–#17: From convergence validity and cross-ethnic equivalence to cognitive interviews and translation equivalence for English translations of scales;
- #18: Under what perturbation conditions do the construct convergence relationships in #14–#17 attenuate or reverse.
These five mainlines are no longer seeking “proof that Vata = Qi-Deficiency” but are shifting toward a more honest direction in scientific philosophy: first defining the conditions under which this hypothesis fails, then determining its validity within the remaining scope. This document serves as the methodological declaration of this shift, incorporating the counter-evidence design of #18 into the empirical claims of #14–#17, explicitly stating convergence criteria, evidence boundaries, and衔接 conditions with the 779 intake / 782 material package.
This document does not extrapolate any cross-civilizational equivalence conclusions to diagnostic, therapeutic, or productized contexts; it only makes a convergence statement regarding the internal logic of Pool5’s own research trajectory.
1. Why “Falsification-Priority” Rather Than “Seeking More Evidence”
Classic Falsificationism (Popper, 1959) requires that a scientific proposition must be falsifiable to qualify as scientific. While Pool5’s writing in rounds 8–14 cited multiple PMID evidences (PMID 29269119, 33068344, 40315935, 36106418, etc.), these evidences were predominantly indirect physiological correlation evidence, rather than direct determinations of “Vata = Qi-Deficiency”.
The logical necessity for direct determination includes:
- Construct Identity: Whether two scales measure the same underlying physiological variable;
- Measurement Invariance: Whether scale scores still point to the same construct under cross-ethnic and cross-linguistic conditions;
- Perturbational Stability: Whether the construct correspondence remains stable under known physiological perturbations.
If only condition 1 is met without testing 2 and 3, “ethnically specific statistical coincidences” are easily misread as “cross-civilizational physiological commonalities”. This is why #18 must stand independently: it opens the “seeking evidence” loop into a “seeking failure conditions” loop.
2. Internal Logic Diagram of the Five Mainlines
#11 Qi-Deficiency RSA Baseline ─┐
├─→ #13 Dual Mapping Hypothesis ─→ #14 Construct Convergence Test
#12 Tridosha RSA Fingerprint ─┘ │
↓
#15/#16 Cross-Ethnic Equivalence (MG-CFA)
│
↓
#17 Scale English Translation Cognitive Interview
│
↓
┌───────────────┴───────────────┐
↓ ↓
#18 Counter-Evidence Boundary Test (H1-H3) 779 Intake Candidate Judgment
(F1-F5 Falsification Conditions)
Note that #18 is not the next piece of evidence following #17, but the logical antithesis of the entire #11–#17 mainline. It must coexist with positive evidence—otherwise, positive evidence remains a single-directional induction.
3. Core Methodological Toolchain
| Tool | Function | Existing Evidence Basis |
|---|---|---|
| HRV Spectral Analysis (LF / HF / RSA) | Measurable outlet for vagal tone | PMID 8598068 (Task Force 1996 HRV Standards) |
| Tridosha Questionnaire (Indian Version) | Quantification of Vata/Pitta/Kapha | PMID 29269119 (Manohar 2018 Tridosha Physiology) |
| QDQ Qi-Deficiency/Qi-Sufficiency Scale (Chinese-English Dual Version) | Quantification of Qi-Deficiency/Qi-Sufficiency | PMID 34479992 (Chung 2021 TCM Syndrome HRV) |
| MG-CFA Three-Step Invariance | Configural / Metric / Scalar | PMID 36106418 (Cross-Ethnic Measurement Invariance Methods) |
| Bland-Altman Agreement | Device/Algorithm Equivalence | Derived application of PMID 8598068 |
| Cognitive Interview + CVI Quantification | Scale Translation Equivalence | Existing #17 Mainline (Delphi + n=20) |
This toolchain constitutes E2-level (indirect evidence assembly), not E1-level (directly measurable). We must clarify the toolchain first to explicitly define failure conditions at each layer within #18’s counter-evidence.
4. Core Structure of #18 Counter-Evidence Design (Aligned with Existing Experimental Design Files)
See 08-ops/experiments/pool5-dosha-qi-rsa-falsification-boundary.md. This document only restates its logical skeleton:
- H1 (Strong Hypothesis): Under resting-state 5-minute short-term + same-model PPG conditions, Vata and Qi-Deficiency scores show Pearson |r| ≥ 0.50, passing all three MG-CFA steps.
- H2 (Moderate Hypothesis): After adding a 24-hour Holter subsample, the correlation coefficient attenuates by ≤ 0.10.
- H3 (Weak Hypothesis / Counter-Evidence Probe): Any of the 5 perturbation types (polarized distribution / caffeine / literal translation / unstandardized / acute illness) causing |r| attenuation ≥ 0.15 is judged as H1 failure.
The falsification conditions F1–F5 are the most critical products of this methodology:
| Falsification Condition | Triggers Downgrade To |
|---|---|
| F1 H1 Not Met | E3, no longer writing “Construct Equivalence” |
| F2 H2 Not Met | Label as “Short-term Specific, Not Extrapolable” |
| F3 ≥ 3 H3 Probes Cause |r| Attenuation ≥ 0.15 | E2, must explain perturbation sensitivity |
| F4 Any Ethnic Scalar Step Fails | “Valid Within Group, Not Comparable Across Ethnicities” |
| F5 Cognitive Interview > 20% Semantic Misunderstanding | Redo Translation; Equivalence Evidence Invalid |
These five falsification conditions transform the question of “whether the hypothesis holds” from a subjective judgment into a mechanical determination writable into protocol.
5. Connection with 779 Intake / 782 Material Package
| Pathway | Entry Condition | Non-Entry Condition |
|---|---|---|
| 779 Intake Candidate | H1 and H2 both pass AND F1–F5 not triggered | Any falsification condition triggered |
| 782 Material Package | After passing 779, Lab engineers decompose “Research Trust Layer” cards | Directly copying raw drafts |
| lab.holyrange.com | Only after 782 slicing completes + source_paths annotated | Directly transmitting science-yixue drafts |
This convergence is the concrete implementation of Charter §0 and §5: the Five Pools do not directly determine the final structure, nor are they directly absorbed by the raw 782 package.
6. Evidence Boundaries
This document is an E3 framework-level statement; evidence boundaries are as follows:
- Does not claim: Vata = Qi-Deficiency, or that the Three-Substance ↔ Qi-Deficiency dual mapping holds clinically;
- Does not extrapolate: Existing physiological evidence to diagnostic, therapeutic, or productized contexts;
- Does not replace: Ongoing empirical research (#11–#17 mainlines);
- Does not assume: Pool5 subsequent rounds will infinitely expand topics—all P1/P2 are completed (Round 13 status); new topics serve only as additions to counter-evidence methods, not production expansion;
- Explicitly states: Current PMID citations (8598068, 29269119, 36106418, 34479992) only support the methodological toolchain and indirect physiological evidence, do not constitute a final judgment on cross-civilizational construct equivalence.
7. Association with Pool5 Completed Work
- Reused the dual-mapping table structure and physiological explanation from
dosha-rsa-qi-deficiency-dual-mapping.md; - Reused the MG-CFA protocol from
dosha-qi-rsa-measurement-invariance-cross-ethnic.md; - Reused the cognitive interview process from
qi-deficiency-english-translation-cross-cultural-equivalence.md; - Reused the construct equivalence argument structure from
qi-deficiency-scale-cross-cultural-construct-equivalence.md; - Concluded the falsification framework from
08-ops/experiments/pool5-dosha-qi-rsa-falsification-boundary.md.
No statements were made that turned “hypotheses” into “proven facts”; this document explicitly lists falsification conditions F1–F5.
Related Reading
- Existing science-yixue articles (in #11–#17 order):
qi-deficiency-rsa-baseline-establishment.mddosha-rsa-fingerprint-cross-cultural.mddosha-rsa-qi-deficiency-dual-mapping.mddosha-qi-rsa-measurement-invariance-cross-ethnic.mdqi-deficiency-scale-cross-cultural-construct-equivalence.mdqi-deficiency-english-translation-cross-cultural-equivalence.md- Experimental Design:
08-ops/experiments/pool5-dosha-qi-rsa-falsification-boundary.md - Pool5 Charter and Backlog:
08-ops/pools/pool5-crosscultural-backlog.md
Citation Evidence Basis
- HRV Measurement Gold Standard: Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996. PMID: 8598068.
- Tridosha Physiology Existing Evidence: Ram Manohar P et al. J Ayurveda Integr Med. 2018. PMID: 29269119.
- Cross-Cultural Measurement Invariance Methods: Mature application of the three-step MG-CFA in psychometrics, referencing cross-ethnic equivalence studies cited in existing science-yixue article
dosha-qi-rsa-measurement-invariance-cross-ethnic.md. PMID: 36106418. - TCM Syndrome and Autonomic Nervous System: Chung JW et al. J Acupunct Meridian Stud. 2021. PMID: 34479992.
This document is a methodological declaration for Pool5’s counter-evidence convergence. Any citation treating this document as “proven cross-civilizational equivalence” must simultaneously cite #18’s falsification design file and respect F1–F5.
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply